《大行報告》瑞銀降舜宇(02382.HK)評級至「中性」 目標價下調至260元
瑞銀髮表研究報告指,舜宇光學科技(02382.HK)在鏡頭模組及鏡頭市場份額持續提升,並保持於車載鏡頭市場的領先地位,但相關利好因素大致上已反映在股價上,因此將評級由「買入」降至「中性」。
該行指出,舜宇的股價過去一年已翻倍,現價水平相當於2021及2022年每股盈利預測的36倍及30倍,屬較高水平。
瑞銀指,舜宇爲Oppo、Vivo及小米(01810.HK)的手機鏡頭供應商,考慮到內地智能手機需求疲弱,加上瑞聲科技(02018.HK)加入競爭,預期中低端手機市場未來競爭將更激烈。
瑞銀預期舜宇今年銷售額將按年增長24%,每股盈利料升26%,將今明兩年每股盈測下調1%及12%,目標價由280元下調至260元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.